M. E. Rothenber, et al., “Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab,” New England Journal of Medicine, Vol. 358, 2008, pp. 12151228. doi:10.1056/NEJMoa070812

has been cited by the following article:

• TITLE: Idiopathic Hypereosinophilic Syndrome Presenting as IgA Nephropathy with Nephrotic Range Proteinuria

  AUTHORS: Tajamul H. Shah, Ajaz N. Koul, Sonaullah Shah, Umar H. Khan, Parvaiz A. Koul, Fayaz A. Sofi, Mufti S., Rafi Ahmed Jan

  KEYWORDS: Idiopathic Hypereosinophilic Syndrome; Eosinophilia; Renal Involvement; Nephrotic Syndrome

  JOURNAL NAME: Open Journal of Nephrology, Vol.3 No.2, June 19, 2013

  ABSTRACT: Idiopathic hypereosinophilic syndrome (IHES) is a disorder characterized by increased eosinophil count (eosinophilia) along with organ dysfunction secondary to organ infiltration of eosinophils and release of inflammatory markers [1-4], with no obvious cause for eosinophilia. The onset of symptoms is insidious in most of the cases and eosinophilia is detected incidentally. However, in others, the initial manifestations are severe and life-threatening due to the rapid evolution of cardiac or neurologic complications [5]. Renal involvement is rarely reported [6] in IHES. Herein we reported a case of IHES with predominant renal involvement as nephrotic syndrome with focal necrotizing IgA nephropathy.